Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,707 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Enrollment posture brief
Registry condition healthy
OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55
Volume-matched condition peers
Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)
Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 17 of 22
Studying Use-Dependent Plasticity
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00067223
Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions
Ranbaxy Laboratories Limited
NCT00776542
PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions
Pfizer
NCT01362673
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
Pfizer
NCT02097329
A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
Eli Lilly and Company
NCT06704763
A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions
Mutual Pharmaceutical Company
NCT00727272
A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function
Eli Lilly and Company
NCT05440344
Nutrition for Health and Performance in Female Collegiate Soccer Players
Case Western Reserve University
NCT06581237
Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds
Pharmanex
NCT02871596
First In Human Study Of Increasing Oral Doses Of PF-04634817
Pfizer
NCT01098877
Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
Wyeth is now a wholly owned subsidiary of Pfizer
NCT00319163
Cefprozil for Oral Suspension 250 mg/5 mL, Fasting
Teva Pharmaceuticals U
NCT00835614
A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions
Actavis
NCT00865410
Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting
Masimo Corporation
NCT04490863
10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
Teva Pharmaceuticals U
NCT01260922
Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)
Pfizer
NCT01918176
A Study of LY3819469 in Participants With Impaired and Normal Renal Function
Eli Lilly and Company
NCT05841277
Cefadroxil 500 mg Capsules Under Fasting Conditions
Teva Pharmaceuticals U
NCT00834275
Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition
Dr. Reddy's Laboratories Limited
NCT01888328
A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions
Actavis
NCT00865111
Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.
Teva Pharmaceuticals U
NCT00835081
Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg
Mylan Pharmaceuticals
NCT00650065
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
Dr. Reddy's Laboratories Limited
NCT01161979
Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Dr. Reddy's Laboratories Limited
NCT01161966
Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mg
Mylan Pharmaceuticals
NCT00649870
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
Masimo Corporation
NCT03124862
A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions
Actavis
NCT00864279
Effects of Commonly Used Medications on Mood and Choice
Johns Hopkins University
NCT03652740
Imaging of Cannabinoid Receptors Using New Radioactive Tracer
National Institute of Mental Health (NIMH)
NCT00450021
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
NuPathe
NCT00546650
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
Beth Israel Deaconess Medical Center
NCT04548349
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
Pfizer
NCT01821066
A Study of LY3819253 (LY-CoV555) in Healthy Participants
Eli Lilly and Company
NCT04537910
Cimetidine Biowaivers
University of Maryland, Baltimore
NCT01256879
The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South
University of Alabama, Tuscaloo
NCT05632575
Quantitative Evaluation of Skin Shrinkage Caused by a Non-invasive Tightening Device
Northwestern University
NCT00894244
A Phase I Study of an HIV Vaccine in Healthy, HIV Uninfected Adults
Crucell Holland
NCT02218125
Cadence Modulation to Improve Well-Being, Kinematics and Aerobic Performance in Cyclists
University of Wisconsin, Madison
NCT03482726
Setria Performance Blend Supplementation
University of North Carolina, Chapel Hill
NCT04090138
Minimally Invasive Biomarker for Asthma Disease Severity
Mayo Clinic
NCT02225678
A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects
KBP Biosciences
NCT04532957
Drug Interaction Study of Isavuconazole and Cyclosporine
Astellas Pharma
NCT01494597
Food Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg
Mylan Pharmaceuticals
NCT00648154
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
Pfizer's Upjohn has merged with Mylan to form Viatris
NCT01321671
Analysis of Atropine and Propranolol Induced Changes
National Institute on Aging (NIA)
NCT00251602
Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects
Rhoshan Pharmaceuticals
NCT05166096
A Study of Perturbation of Human Small Intestinal Colonic Permeability
Mayo Clinic
NCT06033222
The Effects of Walnuts on Antioxidant Capacity and Nutritional Status in Humans
Tufts University
NCT00626691
An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
POZEN
NCT00442208
A Study to Assess Injection Comfort of Two Formulations of ATX-101
Kythera Biopharmaceuticals
NCT01320761
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Named interventions
Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Healthy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Healthy page
1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 225 Healthy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Eli Lilly and Company sponsors the most Healthy trials on record, review their full trial history before evaluating a specific study. See Eli Lilly and Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.